Ticker Details
Cerus Corporation Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
IPO Date:	January 31, 1997
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$462.93M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 2.76%
Avg Daily Range (30 D):	$0.07 | 3.16%
Avg Daily Range (90 D):	$0.06 | 3.31%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	1.31M
Avg Daily Volume (90 D):	1.19M

Trade Size
Avg Trade Size (Sh.):	180
Avg Trade Size (Sh.) (30 D):	175
Avg Trade Size (Sh.) (90 D):	181

Institutional Trades
Total Institutional Trades:	964
Avg Institutional Trade:	$1.27M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$.82M
Avg Institutional Trade Volume:	.25M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.25M
Avg Closing Trade (30 D):	$.54M
Avg Closing Trade (90 D):	$.69M
Avg Closing Volume:	228.64K

News

Jul 17, 2024 @ 12:21 PM ASML Reports Q2 Results, Joins Spirit Airlines And... Source: Avi Kapoor

Jul 17, 2024 @ 10:03 AM Why Bloom Energy Group Shares Are Trading Higher B... Source: Avi Kapoor

Apr 8, 2024 @ 12:24 PM Perion Network Cuts Sales Outlook, Joins Range Res... Source: Avi Kapoor

Mar 21, 2024 @ 3:40 AM Cathie Wood's Ark Invest Sells Another Tranche Of ... Source: Benzinga Neuro

Mar 14, 2024 @ 3:41 AM Cathie Wood's Ark Invest Sells Coinbase Shares As ... Source: Benzinga Neuro

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.08	$	$-.03
Diluted EPS	$-.08	$	$-.03
Revenue	$217.45M	$35.68M	$36.66M
Gross Profit
Net Income / Loss	$-16.02M	$-.02M	$-5.72M
Operating Income / Loss	$-9.49M	$1.24M	$-3.42M
Cost of Revenue
Net Cash Flow	$-6.4M	$-.32M	$-3.45M
PE Ratio